NI201000080A - 4 - [4 - (2-ADAMANTILCARBAMOIL) -5-TERT-BUTYLPYRAZOLE-1-IL] BENZOIC ACID - 465. - Google Patents

4 - [4 - (2-ADAMANTILCARBAMOIL) -5-TERT-BUTYLPYRAZOLE-1-IL] BENZOIC ACID - 465.

Info

Publication number
NI201000080A
NI201000080A NI201000080A NI201000080A NI201000080A NI 201000080 A NI201000080 A NI 201000080A NI 201000080 A NI201000080 A NI 201000080A NI 201000080 A NI201000080 A NI 201000080A NI 201000080 A NI201000080 A NI 201000080A
Authority
NI
Nicaragua
Prior art keywords
tert
benzoic acid
adamantilcarbamoil
butylpyrazole
11bhsd1
Prior art date
Application number
NI201000080A
Other languages
Spanish (es)
Inventor
Stewart Scott James
Robert Owen Whittamore Paul
Stocker Andrew
Packer Martín
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2008/000454 external-priority patent/WO2008099145A1/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NI201000080A publication Critical patent/NI201000080A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El ácido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico y sales farmacéuticamente aceptables de este y una forma cristalina particular del Agente (Forma 1); también se describen su uso en la inhibición de la 11BHSD1, procesos para fabricarlos y composiciones farmacéuticas que los comprenden.4- [4- (2-adamantylcarbamoyl) -5-tert-butylpyrazol-1-yl] benzoic acid and pharmaceutically acceptable salts thereof and a particular crystalline form of the Agent (Form 1); Their use in the inhibition of 11BHSD1, processes for making them and pharmaceutical compositions comprising them are also described.

NI201000080A 2007-11-06 2010-05-06 4 - [4 - (2-ADAMANTILCARBAMOIL) -5-TERT-BUTYLPYRAZOLE-1-IL] BENZOIC ACID - 465. NI201000080A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US98573507P 2007-11-06 2007-11-06
PK10808 2008-02-04
PCT/GB2008/000454 WO2008099145A1 (en) 2007-02-12 2008-02-11 Pyrazole derivatives as 11-beta-hsd1 inhibitors
US8230408P 2008-07-21 2008-07-21

Publications (1)

Publication Number Publication Date
NI201000080A true NI201000080A (en) 2011-03-24

Family

ID=70471663

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201000080A NI201000080A (en) 2007-11-06 2010-05-06 4 - [4 - (2-ADAMANTILCARBAMOIL) -5-TERT-BUTYLPYRAZOLE-1-IL] BENZOIC ACID - 465.

Country Status (1)

Country Link
NI (1) NI201000080A (en)

Similar Documents

Publication Publication Date Title
DOP2010000323A (en) PYRIMIDIN-5-SUBSTITUTED CARBOXAMIDS 281
ES2581331T3 (en) Inhibitor of the progression of a disease attributed to an abnormal accumulation of liver fat
CR20120058A (en) NEW COMPOSITIONS OF 1 - [2 - (2,4-DIMETIL-PHENYL SULFANIL) -PENYL] PIPERAZINA
ECSP11010948A (en) INHIBITORS OF PROTEIN CINASE ENZYMES ACTIVATED BY
UY31456A1 (en) DERIVATIVES OF 2-PIRAZINONA AS INHIBITORS OF THE ELASTASA DE LOS NEUTROFILOS
ECSP10010159A (en) ACID 4- [4- (2-ADAMANTILCARBAMOIL) -5-TERT-BUTILPIRAZOL-1-IL] BENZOICO - 465
ECSP099571A (en) PIRAZOLIC DERIVATIVES AS INHIBITORS OF 11-BETA-HSD1
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
CO6290686A2 (en) DABIGATRAN FOR PERCUTANEOUS INTERVENTIONAL CARDIAC CATHETERING
CO6491060A2 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
NI200800227A (en) 1,3-DIOXANE CARBOXYL ACIDS
UA90742C2 (en) Pyrazolone derivatives
CL2007001752A1 (en) Compound 4- [5 (2-amino-ethanesulfonyl) -isoquinolin-7-yl] -phenolo a pharmaceutically acceptable salt or a hydrate or salt thereof; pharmaceutical composition comprising said compound, lyophilized pharmaceutical composition; and use of the compound as antineiplasic and / or antiviral.
ECSP10010167A (en) NEW OPHTHALMIC COMPOSITIONS
AR063027A1 (en) SULFONAMIDE DERIVATIVES
CO6321285A2 (en) USE OF 3,11B-CIS- DIHIDROTETRABENAZINE IN THE TREATMENT OF MULTIPLE SCLEROSIS AND SELF-IMMUNE HONEY MIELITIS
UY32299A (en) LIQUID PHARMACEUTICAL COMPOSITIONS
UY32954A (en) PYRIMIDINES REPLACED WITH ADAMANTILIMINOCARBONILO AS INHIBITORS OF 11-ß-HSD1 826 ?.
UY33873A (en) PIRAZOL COMPOUNDS AS CRTH2 ANTAGONISTS
MX2012002479A (en) New benzimidazole derivatives and their use as fxr agonists.
NI201000080A (en) 4 - [4 - (2-ADAMANTILCARBAMOIL) -5-TERT-BUTYLPYRAZOLE-1-IL] BENZOIC ACID - 465.
CU20100088A7 (en) ACID 4- [4- (2-ADAMANTILCARBAMOIL) -5-TERT-BUTILPIRAZOL-1-IL] BENZOICO-465
CU20070272A7 (en) PHARMACEUTICAL FORMULATIONS OF IMMEDIATE RELEASE AND WITH A HIGH DRUG LOAD OF (4-CHLOROPHENYL) [4- (4-PIRIDILMETIL) FTALAZIN-1-ILO] MICRONIZED AND ITS SALTS
ECSP11011212A (en) NEW ASSOCIATION OF ACTIVE INGREDIENTS CONTAINING AN ANTI-INFLAMMATORY, NON-STEROID DRUG AND A COLCHICOSIDE DERIVATIVE
ECSP078038A (en) PHARMACEUTICAL FORMULATIONS OF IMMEDIATE RELEASE AND WITH A HIGH DRUG LOAD OF (4-CHLOROPHENYL) [4- (4-PIRIDILMETIL) FTALAZIN-1-ILO] NOT MICRONIZED, AND ITS SALTS